Baxter International Inc. (BAX) produces essential consumable products for hospitals, like IV solutions, that result in predictable cash flow. However, the company is also deep in debt and sells low-margin products. The medtech firm is addressing this concern by diversifying into other products that can generate higher margins.

In this article, we’ll look at BAX’s latest share price, Wall Street sentiment, multiyear price forecasts, and the key factors that are playing a critical role in the company’s path going forward. Table of Contents

Current Stock Overview

Quick Snapshot Table of Predictions & Methodology for Forecasting

Bull & Bear Case

See All 7 Items

Current Stock Overview

Market Cap : $9.41 billion

Trailing P/E Ratio : n/a

Forward P/E Ratio : 7.81

1-Year Return :

See Full Page